Goldman Sachs Maintains Neutral on Cerence, Raises Price Target to $9

Benzinga Newsdesk www.benzinga.com Neutral 53.7%

Neg 0% Neu 53.7% Pos 0%

Goldman Sachs analyst Mark Delaney maintains Cerence (NASDAQ:CRNC) with a Neutral and raises the price target from $8 to $9.